The application of epidural electrical stimulation to the lumbosacral spinal cord in individuals with a spinal cord injury (SCI) facilitates supraspinal control of paralyzed limbs.
1 There is a growing interest in studying whether epidural stimulation can be leveraged to also abrogate cardiovascular dysfunction, as evidenced by ongoing randomized clinical trials on this topic (NCT02037620; NCT03026816). Here, we investigated whether lumbosacral epidural stimulation could be optimized to control cardiovascular functions in the short term, a top health priority and primary cause of death, 2 in 1 individual with a motorcomplete cervical SCI.
Methods | A man in his early 30s with a chronic C5 motorcomplete SCI (ASIA impairment scale B) who was previously (12 months prior) fitted with an epidural spinal cord stimulation unit and 16-electrode array (Restore-ADVANCED and Specify 5-6-5; Medtronic) at T11-L1 vertebral levels was assessed. The placement was confirmed via radiography ( Figure 1A ). The participant gave his written informed consent. This study was approved by the University of British Columbia Clinical Research Ethics Board. We first conducted a series of tests (over 2 weeks) to determine the optimum stimulation parameters to increase blood pressure (BP) in the seated position, ultimately selecting a widefield stimulation configuration ( Figure 1A ; frequency, 35 Hz; pulse width, 300 milliseconds; intensity, 3.5 V). On the main experimental day, we assessed beat-by-beat BP via finger photoplethysmography (Finometer PRO; Finapres Medical Sys- tems) corrected to brachial BP (Dinamap Pro 300V2; General Electric), cardiac function using transthoracic echocardiography (Vivid7; General Electric Healthcare), cerebral blood flow/neurovascular coupling by transcranial Doppler (ST3; Spencer Technologies), and trunk/lower-limb electromyography (Bagnoli; Delsys Inc). All procedures were initially assessed in the supine position and then in response to a 60°h ead-up tilt, with and without epidural stimulation. To confirm the reliability of our findings, we reassessed the blood pressure response to a 60°head-up tilt (with and without stimulation) on 3 separate days.
Results | The stimulation resolved the orthostatic hypotension ( Figure 1B ), which is a debilitating and prevalent condition in SCI. 3 The rise in BP in response to stimulation was well-controlled and did not increase uncontrollably, as it does during autonomic dysreflexia ( Figure 1B) . 4 In the brain, the stimulation prevented the orthostatic-induced 30% decrease in middle cerebral artery blood flow ( Figure 1B ), improved neurovascular coupling ( Figure 1C ), and resolved orthostatic-induced symptoms, including light-headedness, dizziness, and poor concentration, that were self-reported without stimulation. The stimulation also prevented the reduction in cardiac filling (ie, end-diastolic volume) during tilt ( Figure 1D ), thereby preserving stroke volume and cardiac output. The general lack of lower-limb electromyography during stimulation indicates that the skeletal muscle contraction was not leading to venous pump-mediated increases in BP and venous return ( Figure 1E ).
Discussion | To our knowledge, this study is one of the first to demonstrate the acute cardiovascular benefits of lumbosacral epidural stimulation in an individual with SCI that spanned the systemic vasculature, heart, and brain. That we found an immediate benefit in integrated cardiovascular responses raises the possibility that epidural stimulation can excite sympathetic circuitry and instantaneously modulate cardiovascular function in individuals with SCI. The possibility of using electrical spinal cord stimulation to modulate hemodynamics in isolated vascular beds and/or organs has been investigated in various settings and species, with the primary intent of alleviating pain, 5 but to our knowledge, this is one of the first demonstrations that acute lumbosacral epidural stimulation modulates multiple facets of the cardiovascular system concomitantly, following motor-complete cervical SCI. We postulate that epidural stimulation can specifically modulate cardiovascular function by increasing the resting membrane potential of sympathetic circuitry via the stimulation of dorsal afferent relays (Figure 2 ).
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These preliminary data suggest that epidural neuroprosthetics may be a viable approach to manage cardiovascular dysfunction in individuals with chronic SCI and provide an important complement to pharmacological agents that are often slow-acting with undesirable adverse effects.
